• Losing Weight for Less $$$ & You Can’t Pay People to Have Kids

  • Aug 28 2024
  • Duración: 30 m
  • Podcast

Losing Weight for Less $$$ & You Can’t Pay People to Have Kids

  • Resumen

  • Episode 397: Neal and Toby discuss Eli Lilly’s newest form of Zepbound, their blockbuster weight-loss drug that is half the price of its predecessor. Will this eliminate the competition? Then, Mark Zuckerberg writes a letter expressing his regret for demoting Covid-19 content during the pandemic as it felt ‘pressured’ from the Biden administration. Next, the Kelce brothers just scored a massive $100M deal with Amazon to take their podcast to… new heights. Meanwhile, birth rates around the world are falling and some countries are trying to pay people to start families, and it’s not working. Also, dinner sausages are becoming more and more popular as price-conscious shoppers shift to cheaper meats. Lastly, brutal heat waves sweeping across the country are forcing outdoor workers to wear high-tech cooling systems to survive. Visit https://www.massmutual.com/ for all your financial planning needs Get your Morning Brew Daily T-Shirt HERE: https://shop.morningbrew.com/products/morning-brew-radio-t-shirt?_pos=1&_sid=6b0bc409d&_ss=r&variant=45353879044316 Listen to Morning Brew Daily Here: https://link.chtbl.com/MBD Watch Morning Brew Daily Here: https://www.youtube.com/@MorningBrewDailyShow Listen to Money with Katie's podcast on "The Messy Economic Truth that the "Birth Rate Panic" Reveals" Here 00:00 - Shirts at the US Open 02:40 - Eli Lily Cutting Prices 06:30 - Zuck Covid Content Regrets 09:45 - Kelce Mega Podcast Deal 16:00 - South Korean Birth Rate 20:00 - Sausage Impact on the Economy 23:20 - Ice Pack Work Vests Learn more about your ad choices. Visit megaphone.fm/adchoices
    Más Menos
activate_WEBCRO358_DT_T2

Lo que los oyentes dicen sobre Losing Weight for Less $$$ & You Can’t Pay People to Have Kids

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.